(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-N-(quinoxalin-5-ylmethyl)-1,3-oxazolidine-3-carboxamide

C22H16F6N4O3 — CID 129273614

IUPAC(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-N-(quinoxalin-5-ylmethyl)-1,3-oxazolidine-3-carboxamide
SMILESC[C@H]1[C@@H](c2cc(C(F)(F)F)cc(C(F)(F)F)c2)OC(=O)N1C(=O)NCc1cccc2nccnc12
InChIInChI=1S/C22H16F6N4O3/c1-11-18(13-7-14(21(23,24)25)9-15(8-13)22(26,27)28)35-20(34)32(11)19(33)31-10-12-3-2-4-16-17(12)30-6-5-29-16/h2-9,11,18H,10H2,1H3,(H,31,33)/t11-,18-/m0/s1
InChIKeyYHXXNNMVAKYOEP-VOJFVSQTSA-N
MW498.38 g/mol
LogP5.46
Rot. Bonds3

About (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-N-(quinoxalin-5-ylmethyl)-1,3-oxazolidine-3-carboxamide

(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-N-(quinoxalin-5-ylmethyl)-1,3-oxazolidine-3-carboxamide (PubChem CID 129273614) has the molecular formula C22H16F6N4O3 and a molecular weight of 498.38 g/mol. Its IUPAC name is (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-N-(quinoxalin-5-ylmethyl)-1,3-oxazolidine-3-carboxamide.

Molecular Properties

Compound Name(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-N-(quinoxalin-5-ylmethyl)-1,3-oxazolidine-3-carboxamide
PubChem CID129273614
Molecular FormulaC22H16F6N4O3
Molecular Weight498.38 g/mol
Exact Mass498.11
IUPAC Name(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-N-(quinoxalin-5-ylmethyl)-1,3-oxazolidine-3-carboxamide
SMILESC[C@H]1[C@@H](c2cc(C(F)(F)F)cc(C(F)(F)F)c2)OC(=O)N1C(=O)NCc1cccc2nccnc12
InChIInChI=1S/C22H16F6N4O3/c1-11-18(13-7-14(21(23,24)25)9-15(8-13)22(26,27)28)35-20(34)32(11)19(33)31-10-12-3-2-4-16-17(12)30-6-5-29-16/h2-9,11,18H,10H2,1H3,(H,31,33)/t11-,18-/m0/s1
InChIKeyYHXXNNMVAKYOEP-VOJFVSQTSA-N
XLogP5.46
TPSA84.42 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds3
Heavy Atoms35
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500498.38
LogP ≤ 55.46
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-N-(quinoxalin-5-ylmethyl)-1,3-oxazolidine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-N-(quinoxalin-5-ylmethyl)-1,3-oxazolidine-3-carboxamide?
The IUPAC name of (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-N-(quinoxalin-5-ylmethyl)-1,3-oxazolidine-3-carboxamide (CID 129273614) is (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-N-(quinoxalin-5-ylmethyl)-1,3-oxazolidine-3-carboxamide.
What is the SMILES notation for (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-N-(quinoxalin-5-ylmethyl)-1,3-oxazolidine-3-carboxamide?
The canonical SMILES for (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-N-(quinoxalin-5-ylmethyl)-1,3-oxazolidine-3-carboxamide is C[C@H]1[C@@H](c2cc(C(F)(F)F)cc(C(F)(F)F)c2)OC(=O)N1C(=O)NCc1cccc2nccnc12.
What is the InChIKey of (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-N-(quinoxalin-5-ylmethyl)-1,3-oxazolidine-3-carboxamide?
The InChIKey is YHXXNNMVAKYOEP-VOJFVSQTSA-N. The full InChI is InChI=1S/C22H16F6N4O3/c1-11-18(13-7-14(21(23,24)25)9-15(8-13)22(26,27)28)35-20(34)32(11)19(33)31-10-12-3-2-4-16-17(12)30-6-5-29-16/h2-9,11,18H,10H2,1H3,(H,31,33)/t11-,18-/m0/s1.
What are the key properties of (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-N-(quinoxalin-5-ylmethyl)-1,3-oxazolidine-3-carboxamide?
(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-N-(quinoxalin-5-ylmethyl)-1,3-oxazolidine-3-carboxamide has a molecular weight of 498.38 g/mol, XLogP of 5.46, 3 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-N-(quinoxalin-5-ylmethyl)-1,3-oxazolidine-3-carboxamide is sourced from PubChem (CID 129273614), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).